These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8192696)

  • 1. Evaluation of the mutagenicity of 1-hydrazino-4-(3,5-dimethyl-1-pyrazolyl) pyridazino[4,5-b]indole.
    Lopez-de Cerain A; García E; Gullón A; Alvarez T; Losa MJ; Monge A
    Arzneimittelforschung; 1994 Mar; 44(3):310-2. PubMed ID: 8192696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the mutagenicity of chloral hydrate in vitro and in vivo.
    Leuschner J; Leuschner F
    Arzneimittelforschung; 1991 Oct; 41(10):1101-3. PubMed ID: 1799393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxicity and mutagenicity of melanoidins isolated from a roasted glucose-glycine model in human lymphocyte cultures, intestinal Caco-2 cells and in the Salmonella typhimurium strains TA98 and TA102 applying the AMES test.
    Glösl S; Wagner KH; Draxler A; Kaniak M; Lichtenecker S; Sonnleitner A; Somoza V; Erbersdobler H; Elmadfa I
    Food Chem Toxicol; 2004 Sep; 42(9):1487-95. PubMed ID: 15234079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenic and genotoxic activity detected by the Ames, micronucleus and SCE tests under the influence of samples of dyes manufactured in Poland.
    Janik-Spiechowicz E; Dziubałtowska E; Wyszyńska K
    Int J Occup Med Environ Health; 1997; 10(1):55-65. PubMed ID: 9187047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity studies of benzalazine.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1994 Dec; 44(12):1366-8. PubMed ID: 7848359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity studies of muroctasin.
    Shimada H; Hattori C; Sato T
    Arzneimittelforschung; 1988 Jul; 38(7A):1031-3. PubMed ID: 3056424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxicity studies on sertaconazole.
    Romero A; Palacín C; Mosesso P; Hodson-Walker G; Marcos R; Batiste-Alentorn M; Villamayor F; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):743-5. PubMed ID: 1627196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of genotoxicity and mutagenicity of chlorthiophos using micronucleus, chromosome aberration, sister chromatid exchange, and Ames tests.
    Akyıl D; Konuk M
    Environ Toxicol; 2015 Jul; 30(8):937-45. PubMed ID: 24515492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity of the new quinolone antibacterial agent levofloxacin.
    Shimada H; Itoh S; Hattori C; Tada S; Matsuura Y
    Arzneimittelforschung; 1992 Mar; 43(3A):378-85. PubMed ID: 1622436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
    Araki A; Kamigaito N; Sasaki T; Matsushima T
    Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity study of the new cognition-enhancing agent nefiracetam.
    Shimada H; Hattori C; Tanaka N; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):251-3. PubMed ID: 8018099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the mutagenicity of medroxyprogesterone acetate in vitro and in vivo.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1995 Mar; 45(3):311-4. PubMed ID: 7741792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity of condensed pyridazines with different substituents.
    Morita T; Naitou H; Oishi E
    Biol Pharm Bull; 1995 Feb; 18(2):363-7. PubMed ID: 7742814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of methyl tertiary butyl ether.
    Zhou W; Yuan D; Huang G; Zhang H; Ye S
    J Environ Pathol Toxicol Oncol; 2000; 19(1-2):35-9. PubMed ID: 10905506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity and clastogenicity evaluation of tacrine by Ames and micronucleus assays.
    Mulla MS; Vedamurthy RB; Jana S; Pandey SK; Goyal VK; Nirogi R
    Drug Chem Toxicol; 2012 Oct; 35(4):366-70. PubMed ID: 22182316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tofisopam--evaluation of mutagenic and genotoxic properties.
    Chłopkiewicz B; Ejchart A; Anuszewska E
    Acta Pol Pharm; 2001; 58(1):31-4. PubMed ID: 11370285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic toxicity studies with genistein.
    Michael McClain R; Wolz E; Davidovich A; Bausch J
    Food Chem Toxicol; 2006 Jan; 44(1):42-55. PubMed ID: 16198038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clastogenic and mutagenic effects of ascorbigen and 1'-methylascorbigen.
    Musk SR; Preobrazhenskaya MN; Belitsky GA; Korolev AM; Lytcheva TA; Khitrovo IA; Johnson IT
    Mutat Res; 1994; 323(1-2):69-74. PubMed ID: 7508569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of 55 commercial plant extracts in the Ames mutagenicity test.
    Schimmer O; Krüger A; Paulini H; Haefele F
    Pharmazie; 1994 Jun; 49(6):448-51. PubMed ID: 8047546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.